How much funding has Acceleron Pharma raised?

Acceleron Pharma has raised $65.5M in total funding, most recently a corporate round round.

Who are Acceleron Pharma's investors?

Acceleron Pharma's investors include Merck & Co., Polaris Venture Partners, Advanced Technology Ventures, Flagship Ventures, OrbiMed, Venrock.

When was Acceleron Pharma founded?

Acceleron Pharma was founded in 2003.

Where is Acceleron Pharma headquartered?

Acceleron Pharma is headquartered in Cambridge, Massachusetts, United States.

What industry is Acceleron Pharma in?

Acceleron Pharma operates in Biotech, Healthcare.

How many employees does Acceleron Pharma have?

Acceleron Pharma has 201-500 employees.

Acceleron Pharma

Acquired

Merck | Home

Cambridge, United States · Founded 2003 · $65.5M raised

Biotech

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 201–500
Founded: 2003
Business Model: B2B

Website: acceleronpharma.com
Total Funding: $65.5M
Last Round: $25.0M Corporate RoundFeb 2011
Rounds: 4

About

Acceleron Pharma was a Cambridge, Massachusetts-based biopharmaceutical company focused on the discovery and development of transformative therapies that regulate the TGF-β superfamily of proteins. Its lead asset, sotatercept, was a first-in-class activin receptor fusion protein for pulmonary arterial hypertension. Founded in 2003, the company went public in September 2013 on NASDAQ (XLRN) and had approximately 312 employees at the time of its acquisition. Merck acquired Acceleron in November 2021 for $11.5 billion.

Summary

Acceleron Pharma is a Biotech company based in Cambridge, United States, founded in 2003. It has raised $65.5M in total across 4 rounds, most recently a $25.0M Corporate Round round in Feb 2011. Investors include Merck & Co., Polaris Venture Partners and Advanced Technology Ventures.

LinkedIn X (Twitter)